{"title":"大麻类药物作为治疗疼痛的药物","authors":"C. McGaw","doi":"10.7727/WIMJ.2017.192","DOIUrl":null,"url":null,"abstract":"Objective: This review focussed on the role of the endocannabinoid system in relation to pain transmission and modulation. Various facets of both naturally occurring and synthetic cannabinoids (CBs) were explored in an effort to ascertain their suitability in the treatment and management of pain. Methods: The endocannabinoid system and the physiology of CBs were reviewed in isolation and in relation to their hypothesized role in treating pain. Results: Cannabinoids have a more significant effect in instances of chronic pain than acute pain. Inhibitory mechanisms may be more effective than direct activation of the cannabinoid receptors. Many clinical trials of both genuine and synthetic cannabis-mediated analgesia have provided negative or equivocal results. Conclusion: Medications prepared with cannabinoid receptor agonists or with drugs that enhance endocannabinoid function (by either increasing release or diminishing reuptake of endocannabinoids) may afford the novel therapeutic approaches demanded by disorders in which pain is a prominent symptom.","PeriodicalId":49366,"journal":{"name":"West Indian Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2017-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Cannabinoids as Therapeutic Agents in the Management of Pain\",\"authors\":\"C. McGaw\",\"doi\":\"10.7727/WIMJ.2017.192\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: This review focussed on the role of the endocannabinoid system in relation to pain transmission and modulation. Various facets of both naturally occurring and synthetic cannabinoids (CBs) were explored in an effort to ascertain their suitability in the treatment and management of pain. Methods: The endocannabinoid system and the physiology of CBs were reviewed in isolation and in relation to their hypothesized role in treating pain. Results: Cannabinoids have a more significant effect in instances of chronic pain than acute pain. Inhibitory mechanisms may be more effective than direct activation of the cannabinoid receptors. Many clinical trials of both genuine and synthetic cannabis-mediated analgesia have provided negative or equivocal results. Conclusion: Medications prepared with cannabinoid receptor agonists or with drugs that enhance endocannabinoid function (by either increasing release or diminishing reuptake of endocannabinoids) may afford the novel therapeutic approaches demanded by disorders in which pain is a prominent symptom.\",\"PeriodicalId\":49366,\"journal\":{\"name\":\"West Indian Medical Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2017-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"West Indian Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7727/WIMJ.2017.192\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"West Indian Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7727/WIMJ.2017.192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
The Cannabinoids as Therapeutic Agents in the Management of Pain
Objective: This review focussed on the role of the endocannabinoid system in relation to pain transmission and modulation. Various facets of both naturally occurring and synthetic cannabinoids (CBs) were explored in an effort to ascertain their suitability in the treatment and management of pain. Methods: The endocannabinoid system and the physiology of CBs were reviewed in isolation and in relation to their hypothesized role in treating pain. Results: Cannabinoids have a more significant effect in instances of chronic pain than acute pain. Inhibitory mechanisms may be more effective than direct activation of the cannabinoid receptors. Many clinical trials of both genuine and synthetic cannabis-mediated analgesia have provided negative or equivocal results. Conclusion: Medications prepared with cannabinoid receptor agonists or with drugs that enhance endocannabinoid function (by either increasing release or diminishing reuptake of endocannabinoids) may afford the novel therapeutic approaches demanded by disorders in which pain is a prominent symptom.
期刊介绍：
The Journal is international in scope, with author and editorial contributions from across the globe. The focus is on clinical and epidemiological aspects of tropical and infectious diseases, new and re-emerging infections, chronic non-communicable diseases, and medical conditions prevalent in the Latin America-Caribbean region, and of significance to global health, especially in developing countries. The Journal covers all medical disciplines, as well as basic and translational research elucidating the pathophysiologic basis of diseases or focussing on new therapeutic approaches, and publishes original scientific research, reviews, case reports, brief communications, letters, commentaries and medical images. The Journal publishes four to six issues and four supplements annually. English is the language of publication but Abstracts are also duplicated in Spanish. Most of the articles are submitted at the authors’ initiative, but some are solicited by the Editor-in-Chief. Unless expressly stated, the Editorial Board does not accept responsibility for authors’ opinions.
All papers on submission are reviewed by a subcommittee. Those deemed worthy for review are sent to two or three reviewers (one of the three might be a statistician if necessary). The returned papers with reviewer comments are reviewed by the Editor-in-Chief. Papers may be rejected, accepted or sent back to authors for revision. Resubmitted papers from authors are reviewed by the Editor-in-Chief and may be sent back to reviewers or a final decision made by Editor-in-Chief. The decision of the Editorial Board is final with regards to rejected articles. Rejected articles will not be returned to the authors. The editorial subcommittee has the right to return sub-standard manuscripts to the authors, rather than passing them on to the reviewers. This implies outright rejection of the manuscript.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
